查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999058

专用PACS市场：依模式、组件、最终用户和部署方式划分－2026-2032年全球市场预测

Specialty PACS Market by Modality, Component, End User, Deployment - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，专用 PACS 市场价值将达到 53.1 亿美元，到 2026 年将成长到 57.7 亿美元，到 2032 年将达到 97.2 亿美元，复合年增长率为 9.01%。

主要市场统计数据
基准年 2025 53.1亿美元
预计年份：2026年 57.7亿美元
预测年份：2032年 97.2亿美元
复合年增长率 (%) 9.01%

详细概述了临床需求、互通性期望和营运压力如何将专用 PACS 的市场结构转变为以结果为导向的基础设施。

本文概述了专业影像归檔和通讯系统 (PACS) 的现状，阐述了临床需求、技术创新和营运压力之间的相互作用如何影响买卖双方的行为。放射科、循环系统、牙科、整形外科和兽医科的相关人员日益寻求能够提高影像撷取效率、加快影像解读流程并与更广泛的临床和管理生态系统整合的解决方案。随着医疗服务模式的演变，影像基础设施需要超越传统的储存方式，在所有医疗环境中实现安全、即时的存取和长期的影像连续性。

云端原生技术的应用、人工智慧整合、对互通性日益增长的需求以及网路安全的增强，正在如何重新定义整个影像生态系统中医疗服务提供者和供应商的策略？

多项变革正在重塑医疗服务提供者和PACS供应商的策略重点。首先，云端迁移已从「可选项」转变为「核心」必需品。各机构现在正在权衡公共云端云和私有云端的柔软性与本地环境的可控性和延迟问题。这种转变与人工智慧驱动的影像工作流程的兴起密切相关，这些工作流程需要可扩展的运算能力和整合的数据管道来实现分诊、量化和品质保证演算法。

了解 2025 年关税变化对成像技术采购、供应链韧性和采购决策矩阵的多方面影响。

2025年贸易政策变化和关税调整的累积影响，为成像技术​​供应链中的供应商、厂商和经销商带来了复杂的营运和采购挑战。对于伺服器、工作站和储存阵列等设备密集型组件而言，不断上涨的到货成本正在影响采购时机、供应商选择和总体拥有成本 (TCO) 的运算。对于依赖全球零件采购的企业而言，前置作业时间和清关的不确定性进一步凸显了库存缓衝、供应商多元化以及加强交货日期合约保障的必要性。

深入了解最终用户类型、云端与本地部署选择、特定模式需求以及组件级产品组合如何决定差异化产品和上市时间策略。

细分市场的趋势揭示了供应商和医疗系统在调整产品策略以满足买家需求时应考虑的价值来源和部署模式。不同终端使用者（诊所、医院和影像中心）的决策标准各不相同。诊所通常优先考虑易用性、低成本和快速部署，而医院则要求企业级整合、可扩展性和符合内部IT政策。影像中心优先考虑处理能力、不同模式之间的互通性和商业性柔软性。在医院内部，公立和私立机构之间的区别进一步影响采购计划和供应商合作模式；私立医院倾向于追求更快的采购週期和定制化服务合同，而公立医院则在正式的竞标程序和预算限制下运作。

北美、欧洲、中东和非洲以及亚太地区的区域趋势和战略需求正在影响成像解决方案的采用、部署和伙伴关係模式。

区域趋势持续影响着美洲、欧洲、中东和非洲以及亚太地区的市场采纳管道和商业性模式，每个地区都反映了其独特的监管、经济和医疗服务提供的细微差别。在美洲，买家高度重视整合的临床工作流程、合规性以及支援远端影像判读和多站点整合的功能，其中私人医疗系统和大规模诊断连锁机构是先进PACS功能的主要采用者。相较之下，欧洲、中东和非洲的市场格局较为分散，由于各国采购法规、公共医疗系统结构和IT成熟度各不相同，需求也呈现多样化的特征。在这些市场，供应商正透过利用在地化伙伴关係关係、强大的资料居住选项和灵活的商业模式来满足公共竞标和私人医疗机构的需求。

供应商如何利用模组化平台、伙伴关係和不断发展的经营模式，在成像生态系统中平衡技术领先地位和营运可靠性？

专用PACS市场的竞争围绕着三大策略轴：技术差异化、确保互通性和卓越服务。大型成熟供应商正日益将先进的视觉化功能、人工智慧辅助工具和企业级支援服务捆绑在一起，以维繫与大规模医疗系统的合约。同时，中小型专业供应商和创新Start-Ups则透过提供细分领域的临床功能、快速部署和模组化部署选项来竞争。许多公司正在采用平台化方法，整合储存管理、工作流程编配和分析模组，以提高客户留存率并创造提升销售机会。

为供应商和医疗保健领导者提供切实可行的策略步骤，以增强产品差异化、供应链韧性和在各种部署环境中的临床应用。

产业领导企业可以透过专注于技术、商业性协同和营运准备，即时采取策略措施来增强自身竞争优势并改善客户体验。首先，投资于模组化架构，该架构应同时支援私有云端云和公共云端选项，并支援满足不同延迟、安全性和资料居住要求的混合部署。其次，透过优先采用开放标准和强大的API，并简化与电子健康记录、设备供应商和第三方分析工具的集成，来减少采购和部署过程中的摩擦。第三，为人工智慧和进阶视觉化功能建立清晰的临床检验流程。展现可衡量的工作流程优势和诊断效果，可以加速怀疑的临床相关人员的接受度。

我们采用了严谨的混合方法研究途径，结合了对临床医生和供应商的访谈、产品评估、标准分析和检验，以确保研究结果的稳健性和检验。

本调查方法透过整合一手和二手研究，确保研究结果的稳健性、可重复性以及与相关人员实际情况的一致性。一手研究包括对临床医生、IT主管、采购专家和供应商高管进行结构化访谈，以收集关于技术需求、采购障碍、实施经验和服务期望的第一手观点。这些定性见解辅以产品层面的评估以及对供应商文件、技术白皮书和公开监管文件的现场审查，以检验功能集和整合能力。

这个整体结论概述了为什么整合成熟度、检验的临床结果和稳健的经营模式对于成像系统的成功现代化至关重要。

总之，专用PACS系统正处于一个转折点，技术能力、整合成熟度和商业性柔软性将决定哪些解决方案能够带来可持续的临床和营运价值。云端和混合部署模式、人工智慧驱动的工作流程改进以及对互通性和网路安全的日益重视，不再是可选项，而是现代影像专案的必备条件。能够将模组化产品设计、基于服务的经营模式和强大的供应链结合的供应商，最能满足诊所、医院和影像中心等各类客户的多样化需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：专用PACS市场：依模式划分

  • 循环系统
  • 牙科
  • 整形外科
  • 放射科
  • 兽医学

第九章：专用PACS市场：依组件划分

  • 硬体
    • 伺服器
    • 工作站
  • 服务
    • 执行
    • 维护和支援
  • 软体
    • 储存管理
    • 工作流程管理

第十章：专用PACS市场：依最终用户划分

  • 诊所
  • 医院
    • 私人的
    • 民众
  • 影像中心

第十一章：专用PACS市场：依部署类型划分

  • 云
    • 私有云端
    • 公共云端
  • 现场

第十二章：专用PACS市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：专用PACS市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 专用PACS市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国专用PACS市场

第十六章：中国的专用PACS市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert NV
  • Carestream Health, Inc.
  • Change Healthcare LLC
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hyland Software Inc.
  • Intelerad Medical Systems, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Oracle Corporation
  • Sectra AB
  • Siemens Healthineers AG
Product Code: MRR-E370886763A2

The Specialty PACS Market was valued at USD 5.31 billion in 2025 and is projected to grow to USD 5.77 billion in 2026, with a CAGR of 9.01%, reaching USD 9.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.31 billion
Estimated Year [2026] USD 5.77 billion
Forecast Year [2032] USD 9.72 billion
CAGR (%) 9.01%

A thorough overview of how clinical demand, interoperability expectations, and operational pressures are reshaping the specialty PACS landscape into an outcomes-driven infrastructure

The introduction frames the specialty picture archiving and communication systems (PACS) landscape by outlining the confluence of clinical demand, technological innovation, and operational pressures that define buyer and supplier behavior. Radiology, cardiology, dental, orthopedic, and veterinary stakeholders increasingly require solutions that streamline image capture, accelerate interpretation workflows, and integrate with broader clinical and administrative ecosystems. As care delivery models evolve, imaging infrastructure must move beyond traditional storage to enable secure, real-time access and longitudinal image continuity across care settings.

Concurrently, vendors face higher expectations for interoperability, clinical decision support, and measurable contributions to throughput and diagnostic confidence. Given the diversity of deployment environments spanning clinics, hospitals, and imaging centers, design choices that prioritize adaptability, usability, and security become differentiators. The introduction thus sets the stage for a deeper assessment of drivers shaping purchasing behavior, supplier strategies, and the operational challenges that health systems and independent providers must address to realize the value of imaging investments.

How cloud-native evolution, AI integration, heightened interoperability demands, and strengthened cybersecurity are collectively redefining provider and vendor strategies across imaging ecosystems

Several transformative shifts are remapping the strategic priorities of healthcare providers and PACS suppliers alike. First, cloud migration has moved from optional to core; organizations now weigh the flexibility of public and private cloud options against on-premise control and latency concerns. This shift is tightly coupled with the rise of AI-enabled imaging workflows, which demand scalable compute and integrated data pipelines to operationalize algorithms for triage, quantitation, and quality assurance.

Second, interoperability and standards-driven integration have become essential for multi-vendor environments; providers prioritize systems that support industry standards and seamless exchange among electronic health records, modality vendors, and analytics platforms. Third, cybersecurity and data governance have intensified as priorities, prompting investments in encryption, identity management, and secure access models to protect sensitive imaging datasets while enabling authorized remote access. Fourth, economic and operational pressures such as staff shortages and throughput targets are prompting automation and workflow orchestration to reduce repetitive tasks and accelerate reporting. Lastly, distribution channels and partnership models are evolving: vendors are expanding managed services, outcome-based contracts, and cloud-native offerings to align commercial models with provider risk appetites and resource constraints. Taken together, these shifts create an environment where adaptability, clinical integration, and trustworthiness determine long-term success.

Understanding the multifaceted repercussions of 2025 tariff changes on imaging technology procurement, supply chain resilience, and procurement decision matrices

The cumulative impact of trade policy changes and tariff adjustments in 2025 has introduced a complex set of operational and procurement considerations for providers, vendors, and distributors engaged in imaging technology supply chains. Equipment-intensive components such as servers, workstations, and storage arrays have seen upward pressure on landed costs, which in turn influences procurement timing, vendor selection, and the total cost of ownership calculus. For organizations that rely on global component sourcing, lead-time volatility and customs processing variability have emphasized the need for inventory buffers, diversified supplier bases, and stronger contractual protections around delivery windows.

Moreover, the tariff environment has accelerated supplier strategies to localize production, qualify alternate components, or redesign packaging and logistics to reduce duty exposure. As a result, procurement teams increasingly evaluate offers not only on sticker price but on supply chain resilience, after-sales support, and upgrade pathways that minimize exposure to future trade shifts. Importantly, regulatory and reimbursement frameworks interact with tariff impacts because higher upfront hardware costs can influence the attractiveness of cloud or managed service alternatives where capital expenditures are converted into operational spend. In short, tariffs have amplified the importance of supply chain visibility, contractual flexibility, and scenario planning when assessing imaging technology investments.

Actionable insights on how end user types, cloud versus on-premise choices, modality-specific needs, and component-level portfolios dictate differentiated product and go-to-market strategies

Segment-level dynamics reveal distinct value drivers and adoption patterns that suppliers and health systems must consider when aligning product strategy with buyer needs. Based on End User, decision criteria diverge between clinics, hospitals, and imaging centers; clinics typically prioritize ease of use, low overhead, and rapid deployment, whereas hospitals demand enterprise-grade integration, scalability, and compliance with internal IT policies. Imaging centers emphasize throughput, modality interoperability, and commercial flexibility. Within hospitals the distinction between private and public institutions further shapes procurement timelines and vendor engagement models, with private hospitals often pursuing faster procurement cycles and tailored service agreements while public hospitals operate within formal tendering and budgetary constraints.

Based on Deployment, the trade-offs between Cloud and On-Premise persist, with many organizations choosing hybrid approaches that combine the agility of cloud platforms with on-premise control for latency-sensitive workloads. Cloud adoption decisions are nuanced by the choice between Private Cloud and Public Cloud, as both offer different balances of security, performance, and cost transparency. Based on Modality, clinical specialties such as Cardiology, Dental, Orthopedic, Radiology, and Veterinary place unique demands on PACS capabilities; cardiology and radiology require advanced visualization and structured reporting, dental workflows prioritize high-resolution localized imaging and simplified archiving, orthopedic use cases demand integration with pre-operative planning tools, and veterinary practices need flexible licensing models and cross-species imaging templates. Based on Component, supplier portfolios must account for Hardware, Services, and Software. Hardware considerations focus on Servers and Workstations engineered for imaging throughput and resilience. Services span Implementation and Maintenance And Support, where efficient onboarding and SLA-driven support reduce downtime risk. Software capabilities concentrate on Storage Management and Workflow Management, with emphasis on scalable storage architectures and workflow orchestration that accelerates case routing, reporting, and auditability.

Regional dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption, deployment, and partnership models for imaging solutions

Regional dynamics continue to shape adoption pathways and commercial approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography reflecting unique regulatory, economic, and care delivery nuances. In the Americas, buyers place high value on integrated clinical workflows, regulatory compliance, and capabilities that support remote reading and multi-site consolidation; private health systems and large diagnostic chains are central adopters of advanced PACS functionalities. By contrast, Europe, Middle East & Africa exhibits a fragmented landscape where national procurement rules, public health system structures, and varying levels of IT maturity create a patchwork of requirements. In these markets, vendors benefit from localized partnerships, strong data residency options, and flexible commercial models to navigate public tenders and private provider needs.

Meanwhile, Asia-Pacific demonstrates rapid technological adoption in urban centers and a strong appetite for cloud-enabled services and AI-augmented workflows, though uneven infrastructure and local regulatory regimes necessitate tailored deployment strategies. Across regions, reimbursement models, workforce availability, and the maturity of health information exchanges influence whether organizations prioritize on-premise control or cloud-based scalability. Transitioning between these regional environments requires vendors and purchasers to align product roadmaps with local compliance, language support, and channel capabilities while also planning for cross-border interoperability and data governance.

How vendors are leveraging modular platforms, partnerships, and evolving commercial models to balance technological leadership with operational reliability in imaging ecosystems

Competitive behavior in the specialty PACS arena centers on three strategic axes: technological differentiation, interoperability commitments, and service excellence. Leading established vendors increasingly bundle advanced visualization, AI-assisted tools, and enterprise-grade support to retain large health system contracts, while smaller specialist vendors and innovative startups compete by offering niche clinical functionality, rapid implementation, and modular deployment options. Many companies pursue a platform approach that integrates storage management, workflow orchestration, and analytics modules to increase stickiness and create upsell pathways.

Partnerships have become a primary mechanism to extend capabilities quickly; imaging vendors collaborate with cloud providers, AI developers, and system integrators to accelerate time-to-value and expand addressable use cases. Commercial models are also diversifying: aside from traditional perpetual licensing and maintenance, subscription, outcome-based, and managed service offerings create alternatives that align vendor incentives with operational performance. In this context, procurement teams should evaluate vendor roadmaps, interoperability commitments, evidence of clinical validation, and post-deployment service models. For organizations seeking to modernize imaging infrastructure, a careful vendor selection process that balances innovation with proven support mechanisms will be essential to mitigate implementation risk and ensure long-term operability.

Practical strategic steps for vendors and healthcare leaders to strengthen product differentiation, supply chain resilience, and clinical adoption across diverse deployment environments

Industry leaders can take immediate strategic actions to strengthen competitive positioning and enhance customer outcomes by addressing technology, commercial alignment, and operational readiness. First, invest in modular architectures that support both private cloud and public cloud options while enabling hybrid deployments to meet diverse latency, security, and data residency needs. Second, prioritize open standards and robust APIs to simplify integration with electronic health records, modality vendors, and third-party analytics, thereby reducing friction during procurement and deployment. Third, develop clear clinical validation pathways for AI and advanced visualization features; demonstrating measurable workflow benefits and diagnostic impact will accelerate adoption among skeptical clinical stakeholders.

Fourth, reinforce supply chain resilience through supplier diversification, local assembly options, and contractual provisions that protect delivery timelines amidst trade policy shifts. Fifth, expand service portfolios to include managed services, outcome-linked agreements, and modular support tiers that address the needs of clinics, hospitals, and imaging centers. Finally, cultivate partnerships with health systems and clinical champions to co-develop workflow optimizations and training programs that increase clinician confidence and successful uptake. Implementing these recommendations will require cross-functional coordination among product, clinical affairs, and commercial teams, but the payoff will be stronger differentiation and lower total implementation risk for customers.

A rigorous mixed-methods research approach combining clinician and vendor interviews, product assessments, standards analysis, and triangulation to ensure robust and validated findings

The research methodology blends primary and secondary approaches to ensure findings are robust, reproducible, and aligned with stakeholder realities. Primary research included structured interviews with clinicians, IT leaders, procurement specialists, and vendor executives to capture firsthand perspectives on technology requirements, procurement barriers, deployment experiences, and service expectations. These qualitative insights were supplemented by product-level assessments and hands-on reviews of vendor documentation, technical whitepapers, and publicly available regulatory filings to validate feature sets and integration capabilities.

Secondary research encompassed analysis of policy documents, standards organizations, and published clinical validation studies to contextualize regulatory and scientific drivers. Data triangulation techniques were applied to reconcile divergent inputs, and cross-validation with independent domain experts helped refine conclusions and identify potential blind spots. The methodology also incorporated scenario analysis to evaluate supply chain and policy sensitivities. Limitations include variability in regional reporting standards and the dynamic nature of software releases; to mitigate these constraints, the study emphasizes documented capabilities and validated customer experiences rather than speculative product roadmaps.

A synthesized conclusion outlining why integration maturity, validated clinical outcomes, and resilient commercial models are essential for successful imaging modernization

In conclusion, the specialty PACS landscape stands at an inflection point where technology capability, integration maturity, and commercial flexibility determine which solutions deliver sustained clinical and operational value. Cloud and hybrid deployment patterns, AI-enabled workflow augmentation, and heightened emphasis on interoperability and cybersecurity are no longer optional features but foundational requirements for modern imaging programs. Suppliers that align modular product design with service-based commercial models and resilient supply chains will be best positioned to meet diverse customer needs across clinics, hospitals, and imaging centers.

For healthcare organizations, the imperative is to adopt procurement and implementation strategies that prioritize integration, validated clinical outcomes, and supplier accountability. Transitioning to next-generation imaging infrastructure requires careful vendor selection, staged rollout plans, and investment in clinician training and change management. By following evidence-based decision criteria and preparing for policy and supply chain contingencies, both buyers and sellers can accelerate value realization and support improved diagnostic workflows and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Specialty PACS Market, by Modality

  • 8.1. Cardiology
  • 8.2. Dental
  • 8.3. Orthopedic
  • 8.4. Radiology
  • 8.5. Veterinary

9. Specialty PACS Market, by Component

  • 9.1. Hardware
    • 9.1.1. Servers
    • 9.1.2. Workstations
  • 9.2. Services
    • 9.2.1. Implementation
    • 9.2.2. Maintenance And Support
  • 9.3. Software
    • 9.3.1. Storage Management
    • 9.3.2. Workflow Management

10. Specialty PACS Market, by End User

  • 10.1. Clinics
  • 10.2. Hospitals
    • 10.2.1. Private
    • 10.2.2. Public
  • 10.3. Imaging Centers

11. Specialty PACS Market, by Deployment

  • 11.1. Cloud
    • 11.1.1. Private Cloud
    • 11.1.2. Public Cloud
  • 11.2. On-Premise

12. Specialty PACS Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Specialty PACS Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Specialty PACS Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Specialty PACS Market

16. China Specialty PACS Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa-Gevaert N.V.
  • 17.6. Carestream Health, Inc.
  • 17.7. Change Healthcare LLC
  • 17.8. Fujifilm Holdings Corporation
  • 17.9. GE HealthCare Technologies Inc.
  • 17.10. Hyland Software Inc.
  • 17.11. Intelerad Medical Systems, Inc.
  • 17.12. Konica Minolta, Inc.
  • 17.13. Koninklijke Philips N.V.
  • 17.14. Oracle Corporation
  • 17.15. Sectra AB
  • 17.16. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SPECIALTY PACS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SPECIALTY PACS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SPECIALTY PACS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPECIALTY PACS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPECIALTY PACS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SPECIALTY PACS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPECIALTY PACS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SPECIALTY PACS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SPECIALTY PACS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SPECIALTY PACS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPECIALTY PACS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPECIALTY PACS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPECIALTY PACS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPECIALTY PACS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPECIALTY PACS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPECIALTY PACS MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY PACS MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY PACS MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY PACS MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPECIALTY PACS MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPECIALTY PACS MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SPECIALTY PACS MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPECIALTY PACS MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPECIALTY PACS MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPECIALTY PACS MARKET SIZE, BY STORAGE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPECIALTY PACS MARKET SIZE, BY STORAGE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPECIALTY PACS MARKET SIZE, BY STORAGE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKFLOW MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKFLOW MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKFLOW MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPECIALTY PACS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SPECIALTY PACS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPECIALTY PACS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPECIALTY PACS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS SPECIALTY PACS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SPECIALTY PACS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 172. GCC SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. GCC SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. GCC SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 181. GCC SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 202. G7 SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. G7 SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 207. G7 SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. G7 SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 210. G7 SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 211. G7 SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 212. NATO SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. NATO SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 217. NATO SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NATO SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 221. NATO SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)